Log in to save to my catalogue

sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Al...

sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Al...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_66a474839c6c42ef9e3672464afae85b

sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers

About this item

Full title

sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers

Publisher

London: Nature Publishing Group UK

Journal title

EMBO molecular medicine, 2016-05, Vol.8 (5), p.466-476

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

TREM2 is an innate immune receptor expressed on the surface of microglia. Loss‐of‐function mutations of
TREM2
are associated with increased risk of Alzheimer's disease (AD). TREM2 is a type‐1 protein with an ectodomain that is proteolytically cleaved and released into the extracellular space as a soluble variant (sTREM2), which can be measure...

Alternative Titles

Full title

sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early‐stage Alzheimer's disease and associate with neuronal injury markers

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_66a474839c6c42ef9e3672464afae85b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_66a474839c6c42ef9e3672464afae85b

Other Identifiers

ISSN

1757-4676,1757-4684

E-ISSN

1757-4684

DOI

10.15252/emmm.201506123

How to access this item